C07C 211/34
Of a saturated carbon skeleton
Official title: of a saturated carbon skeleton
C07C211/34 (Of a saturated carbon skeleton) appears on 274 US grants and 280 published applications in this corpus.
Search patents in C07C- Granted patents
- 274
- Published applications
- 280
- Assignees
- 202
- Inventors
- 915
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 8 | 0 |
| 1992 | 9 | 0 |
| 1993 | 12 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 5 |
| 2003 | 6 | 5 |
| 2004 | 5 | 11 |
| 2005 | 5 | 10 |
| 2006 | 7 | 8 |
| 2007 | 5 | 6 |
| 2008 | 3 | 5 |
| 2009 | 2 | 2 |
| 2010 | 4 | 9 |
| 2011 | 6 | 17 |
| 2012 | 3 | 11 |
| 2013 | 8 | 14 |
| 2014 | 11 | 16 |
| 2015 | 4 | 17 |
| 2016 | 14 | 21 |
| 2017 | 20 | 15 |
| 2018 | 10 | 24 |
| 2019 | 26 | 12 |
| 2020 | 12 | 13 |
| 2021 | 8 | 16 |
| 2022 | 9 | 12 |
| 2023 | 6 | 11 |
| 2024 | 5 | 9 |
| 2025 | 5 | 8 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ionizable lipid compounds and lipid nanoparticle compositions16 Jun 2026US 12,655,114 B2SunVax mRNA Therapeutics Inc.
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Crystalline salt of eribulin2 Dec 2025US 12,486,283 B2Yonsung Fine Chemical Co., Ltd.
- Arylcyclohexylamine derivatives and process for preparing same11 Nov 2025US 12,466,782 B2Technische Hochschule KöLn
- Use of an amantadine mononitrate compound in manufacture of a medicament for the prevention and treatment of hypertension20 Aug 2026US 2026/0242330 A1Guangzhou Magpie Pharmaceuticals Co., Ltd.
- Epoxy resin curing agent, insulating epoxy resin, and preparation method thereof2 Jul 2026US 2026/0184842 A1Xi' An Jiaotong University
- Process for preparing modulators of eukaryotic initiation factor 2b11 Dec 2025US 2025/0376432 A1Denali Therapeutics Inc.
- Effective means to modulate nmda receptor-mediated toxicity6 Nov 2025US 2025/0339402 A1Fundamental Pharma GmbH
- Compounds30 Oct 2025US 2025/0333371 A1Psylo Pty Ltd
Most cited
By later US patents
- Zeolite SSZ-26122US 4,910,006 AChevron Research Company · 1990
- Diamine terminated primary amine-aldehyde sulfur converting compositions and methods for making and using same76US 7,140,433 B2Clearwater International, LLC · 2006
- Adamantane derivatives in the prevention and treatment of cerebral ischemia75US 5,061,703 AMerz + Co. GmbH & Co. · 1991
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives68US 5,877,218 ATeva Pharmaceutical Industries Ltd. · 1999
- 1-Amino-alkylcyclohexane NMDA receptor antagonists66US 6,034,134 AMerz + Co. GmbH & Co. · 2000